Psychiatric-Mental Health Nurse Practitioner Exam
Psychiatric-Mental Health Nurse Practitioner Exam is a trademark of its owner, which is not affiliated with and does not endorse Test Treasure Publication or TTP Prep.
Psychiatric-Mental Health Nurse Practitioner Exam is a trademark of its owner, which is not affiliated with and does not endorse Test Treasure Publication or TTP Prep.
10 sample questions for the Psychiatric-Mental Health Nurse Practitioner Exam, with the correct answer and an explanation for each. No account needed. Try each one before you open the answer.
Sections covered on the exam: Neuroanatomy, Neurophysiology and Neurodevelopment, Health Promotion, Psychoeducation, Recovery and Resilience, Neurodevelopmental and Child and Adolescent Disorders, Anxiety, Trauma and Obsessive-Compulsive Disorders, Ethics, Legal Principles and Cultural Care.
Question 1 · Neuroanatomy, Neurophysiology and Neurodevelopment
Answer: B. Nigrostriatal pathway
The nigrostriatal pathway runs from the substantia nigra to the striatum and controls motor function, so D2 blockade there produces drug-induced parkinsonism and other extrapyramidal effects. Mesolimbic blockade is the intended antipsychotic action against positive symptoms, and mesocortical hypofunction is linked to negative and cognitive symptoms. Tuberoinfundibular blockade raises prolactin rather than causing rigidity or tremor.
Question 2 · Neuroanatomy, Neurophysiology and Neurodevelopment
Answer: D. Drug-induced inappropriate ADH secretion or effect
Oxcarbazepine (more than carbamazepine) commonly causes SIADH-type hyponatremia, especially in older adults, producing euvolemic hypotonic hyponatremia with inappropriately concentrated urine and high urine sodium. Normal adrenal testing excludes adrenal insufficiency. Primary polydipsia produces maximally dilute urine, usually under 100 mOsm/kg, and he has no diuretic exposure.
Question 3 · Health Promotion, Psychoeducation, Recovery and Resilience
Answer: A. Wait and repeat the COWS until objective withdrawal reaches about 8 to 12
Buprenorphine is a high-affinity partial agonist, so giving it before objective withdrawal, usually a COWS of about 8 to 12 or more, can displace other opioids and precipitate withdrawal. Naltrexone requires 7 to 10 days opioid-free and would precipitate severe withdrawal now. Methadone for opioid use disorder can be dispensed only through an opioid treatment program, and a short taper is not effective treatment.
Question 4 · Neurodevelopmental and Child and Adolescent Disorders
Answer: B. Start clozapine with ANC monitoring per current labeling
Failure of two adequate antipsychotic trials, each at a therapeutic dose for about 6 weeks or more with confirmed adherence, defines treatment-resistant schizophrenia, and clozapine is the only antipsychotic with proven superiority in this group. Trying a third non-clozapine antipsychotic, including a long-acting injectable when adherence is not the problem, yields low response rates. Antipsychotic polypharmacy adds adverse effects without the evidence that clozapine has.
Question 5 · Anxiety, Trauma and Obsessive-Compulsive Disorders
Answer: B. Seek clinical supervision to examine her countertransference
Extended sessions, self-disclosure that serves the clinician and strong personal feelings toward people in the patient's life are signs of countertransference and boundary crossings that can slide into violations, so the PMHNP should use supervision or consultation to understand her reactions and restore the frame. An abrupt transfer without discussion can feel like abandonment to a patient with a trauma history. Continuing unchanged ignores the risk, and advising the patient about her partner acts on the clinician's feelings rather than the patient's goals.
Question 6 · Neuroanatomy, Neurophysiology and Neurodevelopment
Answer: C. NMDA receptor blockade that triggers a glutamate surge
Esketamine blocks NMDA receptors on GABA interneurons, which disinhibits glutamate release; the resulting AMPA receptor activation increases BDNF signaling and rapid synapse formation in the prefrontal cortex within hours to a day. Serotonin reuptake inhibition describes SSRIs, whose benefit takes weeks. Alpha-2 antagonism is the mechanism of mirtazapine, and 5-HT1A partial agonism describes buspirone and vilazodone, none of which act this quickly.
Question 7 · Neuroanatomy, Neurophysiology and Neurodevelopment
Answer: A. Reduced collecting duct response to ADH
Lithium enters collecting duct cells and reduces aquaporin-2 expression, causing nephrogenic diabetes insipidus: dilute urine that does not concentrate after desmopressin, with high-normal sodium. Central diabetes insipidus would respond to desmopressin. Primary polydipsia tends to lower sodium, and normal glucose excludes osmotic diuresis.
Question 8 · Health Promotion, Psychoeducation, Recovery and Resilience
Answer: A. Taper gradually over months, adding CBT for panic disorder
Long-term benzodiazepine use causes physiologic dependence, so discontinuation requires a slow, individualized taper over months, often starting with reductions of about 5 to 10% every 2 to 4 weeks and sometimes after switching to a longer-acting agent, and CBT for panic disorder improves taper success. Abrupt cessation or a rapid 2-week taper risks severe withdrawal, rebound panic and seizures, and propranolol does not prevent seizures. Zolpidem is a Beers list sedative-hypnotic that adds fall risk and does not treat alprazolam withdrawal.
Question 9 · Neurodevelopmental and Child and Adolescent Disorders
Answer: A. Xanomeline-trospium
Xanomeline-trospium acts through central muscarinic M1 and M4 receptor agonism without direct dopamine D2 binding, so it does not raise prolactin; trospium limits peripheral cholinergic effects, and it is avoided in urinary retention and moderate or severe hepatic impairment, which he does not have. Brexpiprazole is a D2 partial agonist, so it still acts directly at dopamine receptors. Lurasidone and olanzapine-samidorphan both block D2 receptors, contrary to his request.
Question 10 · Anxiety, Trauma and Obsessive-Compulsive Disorders
Answer: B. Acceptance and commitment therapy
Acceptance and commitment therapy helps patients stop struggling to control pain and painful thoughts (acceptance and cognitive defusion) and commit to actions guided by their values, such as gardening and family time; it has good evidence in chronic pain. Exposure and response prevention is the first-line therapy for obsessive-compulsive disorder, and EMDR is a trauma-focused therapy for PTSD. Psychodynamic therapy explores unconscious conflict and is not the best-supported choice for pain-related avoidance.
TTP Prep has 200 PMHNP practice questions with explanations, timed and mock-exam modes, 298 flashcards, interactive lessons, a printable cheat sheet and a readiness score. Start free, no card needed.
More free questions: browse every exam.